Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hancock

Showing results (361-370 of 476) with videos related to

Pageof 48
Sort By:
The Health Service Journal|June 22, 1992
Managing risk. A priority in the health serviceI Carruthers, P A Williams, T Elsigood, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1985
Invasiveness and ploidy of human mammary carcinomas in short-term cultureH S Smith, L A Liotta, M C Hancock, et al.
Nursing Management (Harrow, London, England : 1994)|September 1, 1996
The development of nursing and health visiting roles in clinical practiceM P Bull, A Jarvie, Y Moores, et al.
International Journal of Pharmaceutics|June 28, 2002
Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substanceBruno C Hancock, Glenn T Carlson, Dauda D Ladipo, et al.
The Biochemical Journal|September 15, 1994
Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest?M R Bennett, T D Littlewood, D C Hancock, et al.
Oncogene|May 1, 1991
c-myc protein expression in untransformed fibroblastsC M Waters, T D Littlewood, D C Hancock, et al.
FEMS Microbiology Letters|January 11, 2001
A lead-absorbing protein with superoxide dismutase activity from Streptomyces subrutilusN W So, J Y Rho, S Y Lee, et al.
American Journal of Clinical Oncology|December 22, 1999
A phase I/II dose escalation study of carboplatin in the treatment of newly diagnosed patients with advanced ovarian cancer receiving paclitaxelA N Gordon, K C Hancock, C M Matthews, et al.
Frontiers in Immunology|December 26, 2022
Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infectionsMonica D Reece, Colin Song, Sarah C Hancock, et al.
Journal of Virology|May 1, 1991
Characterization and sequence analyses of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein HU A Gompels, A L Carss, C Saxby, et al.
Pageof 48

Showing results (361-370 of 476) with videos related to

Sort By:
Pageof 48
The Health Service Journal|June 22, 1992
Managing risk. A priority in the health serviceI Carruthers, P A Williams, T Elsigood, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1985
Invasiveness and ploidy of human mammary carcinomas in short-term cultureH S Smith, L A Liotta, M C Hancock, et al.
Nursing Management (Harrow, London, England : 1994)|September 1, 1996
The development of nursing and health visiting roles in clinical practiceM P Bull, A Jarvie, Y Moores, et al.
International Journal of Pharmaceutics|June 28, 2002
Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substanceBruno C Hancock, Glenn T Carlson, Dauda D Ladipo, et al.
The Biochemical Journal|September 15, 1994
Down-regulation of the c-myc proto-oncogene in inhibition of vascular smooth-muscle cell proliferation: a signal for growth arrest?M R Bennett, T D Littlewood, D C Hancock, et al.
Oncogene|May 1, 1991
c-myc protein expression in untransformed fibroblastsC M Waters, T D Littlewood, D C Hancock, et al.
FEMS Microbiology Letters|January 11, 2001
A lead-absorbing protein with superoxide dismutase activity from Streptomyces subrutilusN W So, J Y Rho, S Y Lee, et al.
American Journal of Clinical Oncology|December 22, 1999
A phase I/II dose escalation study of carboplatin in the treatment of newly diagnosed patients with advanced ovarian cancer receiving paclitaxelA N Gordon, K C Hancock, C M Matthews, et al.
Frontiers in Immunology|December 26, 2022
Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infectionsMonica D Reece, Colin Song, Sarah C Hancock, et al.
Journal of Virology|May 1, 1991
Characterization and sequence analyses of antibody-selected antigenic variants of herpes simplex virus show a conformationally complex epitope on glycoprotein HU A Gompels, A L Carss, C Saxby, et al.
Pageof 48